Vertex Pharmaceuticals Inc (VRTX)
411.10
+3.41
(+0.84%)
USD |
NASDAQ |
Mar 18, 16:00
410.16
-0.94
(-0.23%)
Pre-Market: 08:25
Vertex Pharmaceuticals Market Cap: 106.19B for March 18, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
March 18, 2024 | 106.19B |
March 15, 2024 | 105.31B |
March 14, 2024 | 105.59B |
March 13, 2024 | 106.73B |
March 12, 2024 | 106.54B |
March 11, 2024 | 107.06B |
March 08, 2024 | 106.83B |
March 07, 2024 | 106.05B |
March 06, 2024 | 106.38B |
March 05, 2024 | 107.31B |
March 04, 2024 | 109.53B |
March 01, 2024 | 111.79B |
February 29, 2024 | 108.68B |
February 28, 2024 | 110.29B |
February 27, 2024 | 111.31B |
February 26, 2024 | 111.97B |
February 23, 2024 | 111.10B |
February 22, 2024 | 110.24B |
February 21, 2024 | 108.39B |
February 20, 2024 | 108.65B |
February 16, 2024 | 109.06B |
February 15, 2024 | 110.11B |
February 14, 2024 | 107.94B |
February 13, 2024 | 107.47B |
February 12, 2024 | 108.11B |
Date | Value |
---|---|
February 09, 2024 | 109.24B |
February 08, 2024 | 109.02B |
February 07, 2024 | 107.99B |
February 06, 2024 | 107.23B |
February 05, 2024 | 110.52B |
February 02, 2024 | 109.44B |
February 01, 2024 | 111.81B |
January 31, 2024 | 111.68B |
January 30, 2024 | 114.95B |
January 29, 2024 | 112.31B |
January 26, 2024 | 110.85B |
January 25, 2024 | 110.80B |
January 24, 2024 | 110.18B |
January 23, 2024 | 113.31B |
January 22, 2024 | 113.41B |
January 19, 2024 | 112.10B |
January 18, 2024 | 111.58B |
January 17, 2024 | 111.78B |
January 16, 2024 | 112.74B |
January 12, 2024 | 111.69B |
January 11, 2024 | 110.83B |
January 10, 2024 | 109.20B |
January 09, 2024 | 108.49B |
January 08, 2024 | 108.01B |
January 05, 2024 | 107.33B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
42.16B
Minimum
May 13 2019
114.95B
Maximum
Jan 30 2024
67.19B
Average
63.86B
Median
Feb 21 2020
Market Cap Benchmarks
Amgen Inc | 145.18B |
Eli Lilly and Co | 724.65B |
Regeneron Pharmaceuticals Inc | 105.34B |
Moderna Inc | 39.83B |
Pfizer Inc | 156.53B |
Market Cap Related Metrics
PE Ratio | 29.60 |
PS Ratio | 10.85 |
PEG Ratio | 3.582 |
Price to Book Value | 6.040 |
Price to Free Cash Flow | 32.66 |
Price | 411.10 |
Earnings Yield | 3.38% |
PEGY Ratio | 3.582 |
Operating PE Ratio | 24.86 |
Normalized PE Ratio | 26.81 |